title: Risk factors for hepatotoxicity in patients treated with highly active antiretroviral therapy.
authors.forename: P
authors.initials: P
authors.lastname: Bonfanti
authors.forename: S
authors.initials: S
authors.lastname: Landonio
authors.forename: E
authors.initials: E
authors.lastname: Ricci
authors.forename: C
authors.initials: C
authors.lastname: Martinelli
authors.forename: P
authors.initials: P
authors.lastname: Fortuna
authors.forename: I
authors.initials: I
authors.lastname: Faggion
authors.forename: T
authors.initials: T
authors.lastname: Quirino
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D015331:Cohort Studies; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007558:Italy; D008099:Liver / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016016:Proportional Hazards Models; D011446:Prospective Studies; D011480:Protease Inhibitors / Q000009:adverse effects*; D012307:Risk Factors
chemical_list: D011480:Protease Inhibitors